{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:34:00Z","timestamp":1773351240935,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00059-026-05369-7","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:25:22Z","timestamp":1770996322000},"page":"81-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Herzrhythmusst\u00f6rungen\u00a0\u2013 Zellul\u00e4re Mechanismen, Konsequenzen und Herausforderungen in der Diagnostik mittels humaner Modelle","Cardiac arrhythmias\u2014Cellular mechanisms, consequences and challenges in the diagnostics using human models"],"prefix":"10.1007","volume":"51","author":[{"given":"Katrin","family":"Streckfu\u00df-B\u00f6meke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Maack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Sossalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"5369_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41436-020-00946-5","volume":"23","author":"R Walsh","year":"2021","unstructured":"Walsh\u00a0R et\u00a0al (2021) Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls. Genet Med 23:47\u201358. https:\/\/doi.org\/10.1038\/s41436-020-00946-5","journal-title":"Genet Med"},{"key":"5369_CR2","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-j","volume":"20","author":"P Brugada","year":"1992","unstructured":"Brugada\u00a0P, Brugada\u00a0J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a multicenter report. J\u00a0Am Coll Cardiol 20:1391\u20131396. https:\/\/doi.org\/10.1016\/0735-1097(92)90253-j","journal-title":"J Am Coll Cardiol"},{"key":"5369_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.hlc.2019.10.013","volume":"29","author":"A Pflaumer","year":"2020","unstructured":"Pflaumer\u00a0A, Wilde\u00a0AAM, Charafeddine\u00a0F, Davis\u00a0AM (2020) 50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Time to Explore the Dark Side of the Moon. Heart Lung Circ 29:520\u2013528. https:\/\/doi.org\/10.1016\/j.hlc.2019.10.013","journal-title":"Heart Lung Circ"},{"key":"5369_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1172\/JCI19844","volume":"112","author":"RS Kass","year":"2003","unstructured":"Kass\u00a0RS, Moss\u00a0AJ (2003) Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J\u00a0Clin Invest 112:810\u2013815. https:\/\/doi.org\/10.1172\/JCI19844","journal-title":"J Clin Invest"},{"key":"5369_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000047299","volume":"94","author":"I Gussak","year":"2000","unstructured":"Gussak\u00a0I et\u00a0al (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94:99\u2013102. https:\/\/doi.org\/10.1159\/000047299","journal-title":"Cardiology"},{"key":"5369_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-025-01972-0","author":"RLM Griffiths","year":"2025","unstructured":"Griffiths\u00a0RLM, Walsh\u00a0R, Futema\u00a0M, Specterman\u00a0M, Behr\u00a0ER (2025) Brugada Syndrome: an exemplar for the genomic basis of sudden death. Eur J Hum Genet. https:\/\/doi.org\/10.1038\/s41431-025-01972-0","journal-title":"Eur J Hum Genet"},{"key":"5369_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/ah9.0000000000000018","volume":"1","author":"S Luo","year":"2025","unstructured":"Luo\u00a0S, Gomez\u00a0AM (2025) Catecholaminergic polymorphic ventricular tachycardia: A narrative review of recent advances in genetics, mechanisms, diagnosis, and treatment. Asian Heart J 1:97\u2013110. https:\/\/doi.org\/10.1097\/ah9.0000000000000018","journal-title":"Asian Heart J"},{"key":"5369_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.119.043132","volume":"141","author":"A Adler","year":"2020","unstructured":"Adler\u00a0A et\u00a0al (2020) An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 141:418\u2013428. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043132","journal-title":"Circulation"},{"key":"5369_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jelectrocard.2024.04.009","volume":"85","author":"AR Perez-Riera","year":"2024","unstructured":"Perez-Riera\u00a0AR et\u00a0al (2024) Congenital short QT syndrome: A review focused on electrocardiographic features. J\u00a0Electrocardiol 85:87\u201394. https:\/\/doi.org\/10.1016\/j.jelectrocard.2024.04.009","journal-title":"J Electrocardiol"},{"key":"5369_CR10","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K et\u00a0al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J Qual Care Clin Outcomes 43:3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"key":"5369_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G et\u00a0al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J Qual Care Clin Outcomes 42:373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"5369_CR12","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA et\u00a0al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J Qual Care Clin Outcomes 42:3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"5369_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/s0735-1097(98)00297-6","volume":"32","author":"DL Dries","year":"1998","unstructured":"Dries\u00a0DL et\u00a0al (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. JACC Adv 32:695\u2013703. https:\/\/doi.org\/10.1016\/s0735-1097(98)00297-6","journal-title":"J Am Coll Cardiol"},{"key":"5369_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3238\/arztebl.2018.0335","volume":"115","author":"S Sossalla","year":"2018","unstructured":"Sossalla\u00a0S, Vollmann\u00a0D (2018) Arrhythmia-Induced Cardiomyopathy. Dtsch Arztebl Int 115:335\u2013341. https:\/\/doi.org\/10.3238\/arztebl.2018.0335","journal-title":"Dtsch Arztebl Int"},{"key":"5369_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01195-2","author":"L Fabritz","year":"2025","unstructured":"Fabritz\u00a0L, Hatem\u00a0SN, Sossalla\u00a0S (2025) Arrhythmia-induced cardiomyopathy: focus on atrial fibrillation. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-025-01195-2","journal-title":"Nat Rev Cardiol"},{"key":"5369_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jacep.2024.102332","volume":"10","author":"C Schach","year":"2024","unstructured":"Schach\u00a0C et\u00a0al (2024) Clinical Characterization of Arrhythmia-Induced Cardiomyopathy in Patients With Tachyarrhythmia and Idiopathic Heart Failure. JACC Clin Electrophysiol 10:870\u2013881. https:\/\/doi.org\/10.1016\/j.jacep.2024.102332","journal-title":"JACC Clin Electrophysiol"},{"key":"5369_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.70069","author":"M Luedde","year":"2025","unstructured":"Luedde\u00a0M et\u00a0al (2025) European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.70069","journal-title":"Eur J Heart Fail"},{"key":"5369_CR18","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof\u00a0P et\u00a0al (2020) Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med 383:1305\u20131316. https:\/\/doi.org\/10.1056\/NEJMoa2019422","journal-title":"N Engl J Med"},{"key":"5369_CR19","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","volume":"70","author":"S Prabhu","year":"2017","unstructured":"Prabhu\u00a0S et\u00a0al (2017) Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study. JACC Adv 70:1949\u20131961. https:\/\/doi.org\/10.1016\/j.jacc.2017.08.041","journal-title":"J Am Coll Cardiol"},{"key":"5369_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/europace\/euz013","volume":"21","author":"B Muller-Edenborn","year":"2019","unstructured":"Muller-Edenborn\u00a0B et\u00a0al (2019) Rapid improvement in left ventricular function after sinus rhythm restoration in patients with idiopathic cardiomyopathy and atrial fibrillation. Europace 21:871\u2013878. https:\/\/doi.org\/10.1093\/europace\/euz013","journal-title":"Europace"},{"key":"5369_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche\u00a0NF et\u00a0al (2018) Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 378:417\u2013427. https:\/\/doi.org\/10.1056\/NEJMoa1707855","journal-title":"N Engl J Med"},{"key":"5369_CR22","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","volume":"389","author":"C Sohns","year":"2023","unstructured":"Sohns\u00a0C et\u00a0al (2023) Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. N Engl J Med 389:1380\u20131389. https:\/\/doi.org\/10.1056\/NEJMoa2306037","journal-title":"N Engl J Med"},{"key":"5369_CR23","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder\u00a0IC et\u00a0al (2024) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J Qual Care Clin Outcomes 45:3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"key":"5369_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/eurheartj\/ehaf563","volume":"47","author":"L Segan","year":"2026","unstructured":"Segan\u00a0L et\u00a0al (2026) Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial. Eur Heart J Qual Care Clin Outcomes 47:250\u2013262. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf563","journal-title":"Eur Heart J"},{"key":"5369_CR25","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1093\/eurheartj\/ehac257","volume":"43","author":"S. Pabel","year":"2022","unstructured":"Pabel\u00a0S, Sossalla\u00a0S (2022) Atrial fibrillation and heart failure: novel insights into the chicken and egg dilemma. Eur Heart J Qual Care Clin Outcomes 43:3376\u20133378. https:\/\/doi.org\/10.1093\/eurheartj\/ehac257","journal-title":"Eur Heart J"},{"key":"5369_CR26","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/CIRCULATIONAHA.116.022931","volume":"134","author":"RS Wijesurendra","year":"2016","unstructured":"Wijesurendra\u00a0RS et\u00a0al (2016) Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation. Circulation 134:1068\u20131081. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022931","journal-title":"Circulation"},{"key":"5369_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-025-01167-6","volume":"22","author":"D Aksentijevic","year":"2025","unstructured":"Aksentijevic\u00a0D et\u00a0al (2025) Mechano-energetic uncoupling in heart failure. Nat Rev Cardiol 22:773\u2013797. https:\/\/doi.org\/10.1038\/s41569-025-01167-6","journal-title":"Nat Rev Cardiol"},{"key":"5369_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00059-022-05161-3","volume":"48","author":"C Maack","year":"2023","unstructured":"Maack\u00a0C (2023) Mechano-energetic defects in heart failure. Herz 48:123\u2013133. https:\/\/doi.org\/10.1007\/s00059-022-05161-3","journal-title":"Herz"},{"key":"5369_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01167-6","author":"D Aksentijevic","year":"2025","unstructured":"Aksentijevic\u00a0D et\u00a0al (2025) Mechano-energetic uncoupling in heart failure. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-025-01167-6","journal-title":"Nat Rev Cardiol"},{"key":"5369_CR30","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.125.074120","volume":"152","author":"A Xu","year":"2025","unstructured":"Xu\u00a0A et\u00a0al (2025) Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy. Circulation 152:1705\u20131727. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.074120","journal-title":"Circulation"},{"key":"5369_CR31","doi-asserted-by":"publisher","unstructured":"Kohlhaas M et\u00a0al (2024) Mitochondrial reactive oxygen species cause arrhythmias in hypertrophic cardiomyopathy. https:\/\/doi.org\/10.1101\/2024.10.02.616214","DOI":"10.1101\/2024.10.02.616214"},{"key":"5369_CR32","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1161\/CIRCULATIONAHA.121.053755","volume":"144","author":"E Bertero","year":"2021","unstructured":"Bertero\u00a0E et\u00a0al (2021) Loss of Mitochondrial Ca(2+) Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy. Circulation 144:1694\u20131713. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053755","journal-title":"Circulation"},{"key":"5369_CR33","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/CIRCRESAHA.124.325658","volume":"137","author":"JRD Pronto","year":"2025","unstructured":"Pronto\u00a0JRD et\u00a0al (2025) Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial Fibrillation. Circ Res 137:1333\u20131352. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.325658","journal-title":"Circ Res"},{"key":"5369_CR34","doi-asserted-by":"publisher","unstructured":"Forelli N et\u00a0al (2024) SGLT2 inhibitors activate pantothenate kinase in the human heart. https:\/\/doi.org\/10.1101\/2024.07.26.605401","DOI":"10.1101\/2024.07.26.605401"},{"key":"5369_CR35","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun\u00a0D, Gao\u00a0W, Hu\u00a0H, Zhou\u00a0S (2022) Why 90\u202f% of clinical drug development fails and how to improve it? Acta Pharm Sin B 12:3049\u20133062. https:\/\/doi.org\/10.1016\/j.apsb.2022.02.002","journal-title":"Acta Pharm Sin B"},{"key":"5369_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","volume":"81","author":"T Colatsky","year":"2016","unstructured":"Colatsky\u00a0T et\u00a0al (2016) The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress. J\u00a0Pharmacol Toxicol Methods 81:15\u201320. https:\/\/doi.org\/10.1016\/j.vascn.2016.06.002","journal-title":"J Pharmacol Toxicol Methods"},{"key":"5369_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175824","author":"PH Zushin","year":"2023","unstructured":"Zushin\u00a0PH, Mukherjee\u00a0S, Wu\u00a0JC (2023) FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J\u00a0Clin Invest. https:\/\/doi.org\/10.1172\/JCI175824","journal-title":"J Clin Invest"},{"key":"5369_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116036","volume":"170","author":"JH Amesz","year":"2024","unstructured":"Amesz\u00a0JH et\u00a0al (2024) Biomechanical response of ultrathin slices of hypertrophic cardiomyopathy tissue to myosin modulator mavacamten. Biomed Pharmacother 170:116036. https:\/\/doi.org\/10.1016\/j.biopha.2023.116036","journal-title":"Biomed Pharmacother"},{"key":"5369_CR39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.3644","volume":"27","author":"T Krammer","year":"2025","unstructured":"Krammer\u00a0T et\u00a0al (2025) Cardioprotective effects of semaglutide on isolated human ventricular myocardium. ESC Heart Fail 27:1315\u20131325. https:\/\/doi.org\/10.1002\/ejhf.3644","journal-title":"Eur J Heart Fail"},{"key":"5369_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01044-5","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou\u00a0B et\u00a0al (2022) Functional isolation, culture and cryopreservation of adult human primary cardiomyocytes. Signal Transduct Target Ther 7:254. https:\/\/doi.org\/10.1038\/s41392-022-01044-5","journal-title":"Signal Transduct Target Ther"},{"key":"5369_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26690-1","volume":"12","author":"P Bengel","year":"2021","unstructured":"Bengel\u00a0P et\u00a0al (2021) Detrimental proarrhythmogenic interaction of Ca(2+)\/calmodulin-dependent protein kinase II and Na(V)1.8 in heart failure. Nat Commun 12:6586. https:\/\/doi.org\/10.1038\/s41467-021-26690-1","journal-title":"Nat Commun"},{"key":"5369_CR42","doi-asserted-by":"publisher","DOI":"10.1098\/rsta.2023.0384","volume":"383","author":"A Loewe","year":"2025","unstructured":"Loewe\u00a0A, Hunter\u00a0PJ, Kohl\u00a0P (2025) Computational modelling of biological systems now and then: revisiting tools and visions from the beginning of the century. Philos Trans A Math Phys Eng Sci 383:20230384. https:\/\/doi.org\/10.1098\/rsta.2023.0384","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"5369_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99941","author":"L Cyganek","year":"2018","unstructured":"Cyganek\u00a0L et\u00a0al (2018) Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.99941","journal-title":"JCI Insight"},{"key":"5369_CR44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s44161-024-00471-7","volume":"3","author":"H Hamidzada","year":"2024","unstructured":"Hamidzada\u00a0H et\u00a0al (2024) Primitive macrophages induce sarcomeric maturation and functional enhancement of developing human cardiac microtissues via efferocytic pathways. Nat Cardiovasc Res 3:567\u2013593. https:\/\/doi.org\/10.1038\/s44161-024-00471-7","journal-title":"Nat Cardiovasc Res"},{"key":"5369_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biomaterials.2018.11.032","volume":"194","author":"SL Natividad-Diaz","year":"2019","unstructured":"Natividad-Diaz\u00a0SL et\u00a0al (2019) A combined hiPSC-derived endothelial cell and in vitro microfluidic platform for assessing biomaterial-based angiogenesis. Biomaterials 194:73\u201383. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.11.032","journal-title":"Biomaterials"},{"key":"5369_CR46","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","volume":"363","author":"A Moretti","year":"2010","unstructured":"Moretti\u00a0A et\u00a0al (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363:1397\u20131409. https:\/\/doi.org\/10.1056\/NEJMoa0908679","journal-title":"N Engl J Med"},{"key":"5369_CR47","doi-asserted-by":"publisher","unstructured":"Rebs S et\u00a0al (2025) RBM20-variants induce distinct calcium handling and metabolic phenotypes in patient-specific stem cell models of dilated and non-compaction cardiomyopathy. https:\/\/doi.org\/10.1101\/2025.01.13.632728","DOI":"10.1101\/2025.01.13.632728"},{"key":"5369_CR48","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013074","volume":"13","author":"F Cuello","year":"2021","unstructured":"Cuello\u00a0F et\u00a0al (2021) Impairment of the ER\/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation. EMBO Mol Med 13:e13074. https:\/\/doi.org\/10.15252\/emmm.202013074","journal-title":"EMBO Mol Med"},{"key":"5369_CR49","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s44161-025-00669-3","volume":"4","author":"MW Pocock","year":"2025","unstructured":"Pocock\u00a0MW et\u00a0al (2025) Maturation of human cardiac organoids enables complex disease modeling and drug discovery. Nat Cardiovasc Res 4:821\u2013840. https:\/\/doi.org\/10.1038\/s44161-025-00669-3","journal-title":"Nat Cardiovasc Res"},{"key":"5369_CR50","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.stem.2024.08.008","volume":"31","author":"J Li","year":"2024","unstructured":"Li\u00a0J et\u00a0al (2024) Modeling the atrioventricular conduction axis using human pluripotent stem cell-derived cardiac assembloids. Cell Stem Cell 31:1667\u20131684. https:\/\/doi.org\/10.1016\/j.stem.2024.08.008","journal-title":"Cell Stem Cell"},{"key":"5369_CR51","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.116.024145","volume":"135","author":"M Tiburcy","year":"2017","unstructured":"Tiburcy\u00a0M et\u00a0al (2017) Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair. Circulation 135:1832\u20131847. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024145","journal-title":"Circulation"},{"key":"5369_CR52","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jacc.2017.06.061","volume":"70","author":"T Borchert","year":"2017","unstructured":"Borchert\u00a0T et\u00a0al (2017) Catecholamine-Dependent beta-Adrenergic Signaling in a Pluripotent Stem Cell Model of Takotsubo Cardiomyopathy. JACC Adv 70:975\u2013991. https:\/\/doi.org\/10.1016\/j.jacc.2017.06.061","journal-title":"J Am Coll Cardiol"},{"key":"5369_CR53","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s44161-023-00378-9","volume":"2","author":"E Kyriakopoulou","year":"2023","unstructured":"Kyriakopoulou\u00a0E et\u00a0al (2023) Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy. Nat Cardiovasc Res 2:1262\u20131276. https:\/\/doi.org\/10.1038\/s44161-023-00378-9","journal-title":"Nat Cardiovasc Res"},{"key":"5369_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yjmcc.2017.09.008","volume":"113","author":"K Streckfuss-Bomeke","year":"2017","unstructured":"Streckfuss-Bomeke\u00a0K et\u00a0al (2017) Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes. J\u00a0Mol Cell Cardiol Plus 113:9\u201321. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.09.008","journal-title":"J Mol Cell Cardiol"},{"key":"5369_CR55","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-024-08463-0","volume":"639","author":"AF Jebran","year":"2025","unstructured":"Jebran\u00a0AF et\u00a0al (2025) Engineered heart muscle allografts for heart repair in primates and humans. Nat Cell Biol 639:503\u2013511. https:\/\/doi.org\/10.1038\/s41586-024-08463-0","journal-title":"Nature"},{"key":"5369_CR56","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911115","volume":"11","author":"M Prondzynski","year":"2019","unstructured":"Prondzynski\u00a0M et\u00a0al (2019) Disease modeling of a mutation in alpha-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy. EMBO Mol Med 11:e11115. https:\/\/doi.org\/10.15252\/emmm.201911115","journal-title":"EMBO Mol Med"},{"key":"5369_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312990","author":"F Sedaghat-Hamedani","year":"2021","unstructured":"Sedaghat-Hamedani\u00a0F et\u00a0al (2021) Identification of SCN5a p.C335R Variant in a Large Family with Dilated Cardiomyopathy and Conduction Disease. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms222312990","journal-title":"Int J Mol Sci"},{"key":"5369_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210189","author":"N Hartmann","year":"2023","unstructured":"Hartmann\u00a0N et\u00a0al (2023) Molecular and Functional Relevance of Na(V)1.8-Induced Atrial Arrhythmogenic Triggers in a Human SCN10A Knock-Out Stem Cell Model. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms241210189","journal-title":"Int J Mol Sci"},{"key":"5369_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2021.102263","volume":"53","author":"S Rebs","year":"2021","unstructured":"Rebs\u00a0S et\u00a0al (2021) Generation and cardiac differentiation of an induced pluripotent stem cell line from a patient with arrhythmia-induced cardiomyopathy. Stem Cell Res 53:102263. https:\/\/doi.org\/10.1016\/j.scr.2021.102263","journal-title":"Stem Cell Res"},{"key":"5369_CR60","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jacep.2022.07.016","volume":"8","author":"T Kortl","year":"2022","unstructured":"Kortl\u00a0T et\u00a0al (2022) Atrial Fibrillation Burden Specifically Determines Human Ventricular Cellular Remodeling. JACC Clin Electrophysiol 8:1357\u20131366. https:\/\/doi.org\/10.1016\/j.jacep.2022.07.016","journal-title":"JACC Clin Electrophysiol"},{"key":"5369_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.70051","author":"M Knierim","year":"2025","unstructured":"Knierim\u00a0M et\u00a0al (2025) Atrial fibrillation in end-stage heart failure: Cellular mechanisms behind CASTLE-HTx. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.70051","journal-title":"Eur J Heart Fail"},{"key":"5369_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2025.102757","volume":"21","author":"B Gomes-Silva","year":"2026","unstructured":"Gomes-Silva\u00a0B et\u00a0al (2026) Alternative splicing dynamics during human cardiac development in vivo and in vitro. Stem Cell Reports 21:102757. https:\/\/doi.org\/10.1016\/j.stemcr.2025.102757","journal-title":"Stem Cell Reports"},{"key":"5369_CR63","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.yjmcc.2021.12.001","volume":"164","author":"G Emanuelli","year":"2022","unstructured":"Emanuelli\u00a0G et\u00a0al (2022) A roadmap for the characterization of energy metabolism in human cardiomyocytes derived from induced pluripotent stem cells. J\u00a0Mol Cell Cardiol Plus 164:136\u2013147. https:\/\/doi.org\/10.1016\/j.yjmcc.2021.12.001","journal-title":"J Mol Cell Cardiol"},{"key":"5369_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107925","volume":"32","author":"DAM Feyen","year":"2020","unstructured":"Feyen\u00a0DAM et\u00a0al (2020) Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes. Cell Rep Med 32:107925. https:\/\/doi.org\/10.1016\/j.celrep.2020.107925","journal-title":"Cell Rep"},{"key":"5369_CR65","doi-asserted-by":"publisher","first-page":"H1244","DOI":"10.1152\/ajpheart.00536.2024","volume":"327","author":"M Knierim","year":"2024","unstructured":"Knierim\u00a0M et\u00a0al (2024) Cellular calcium handling and electrophysiology are modulated by chronic physiological pacing in human induced pluripotent stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 327:H1244\u2013H1254. https:\/\/doi.org\/10.1152\/ajpheart.00536.2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5369_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58044-6","volume":"16","author":"W Li","year":"2025","unstructured":"Li\u00a0W et\u00a0al (2025) Comprehensive promotion of iPSC-CM maturation by integrating metabolic medium with nanopatterning and electrostimulation. Nat Commun 16:2785. https:\/\/doi.org\/10.1038\/s41467-025-58044-6","journal-title":"Nat Commun"},{"key":"5369_CR67","doi-asserted-by":"publisher","unstructured":"Rebs S et\u00a0al (2025) Enhanced iPSC-Cardiomyocyte Maturation via Combined 3D-Culture and Metabolic Cues. https:\/\/doi.org\/10.1101\/2025.10.29.684362","DOI":"10.1101\/2025.10.29.684362"},{"key":"5369_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.108082","volume":"178","author":"S Schmeisser","year":"2023","unstructured":"Schmeisser\u00a0S et\u00a0al (2023) New approach methodologies in human regulatory toxicology - Not if, but how and when! Environ Int 178:108082. https:\/\/doi.org\/10.1016\/j.envint.2023.108082","journal-title":"Environ Int"},{"key":"5369_CR69","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1093\/eurheartj\/ehae519","volume":"45","author":"X Wu","year":"2024","unstructured":"Wu\u00a0X et\u00a0al (2024) Clinical trials in-a-dish for cardiovascular medicine. Eur Heart J Qual Care Clin Outcomes 45:4275\u20134290. https:\/\/doi.org\/10.1093\/eurheartj\/ehae519","journal-title":"Eur Heart J"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-026-05369-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-026-05369-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-026-05369-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:55:37Z","timestamp":1773312937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-026-05369-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5369"],"URL":"https:\/\/doi.org\/10.1007\/s00059-026-05369-7","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Maack erhielt Honorare als Referent oder Berater von AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Cytokinetics, Lilly und Novo Nordisk. S.\u00a0Sossalla erhielt Honorare als Referent oder Berater von AstraZeneca, Novartis, Berlin-Chemie, Bristol-Meyers Squibb, Boehringer Ingelheim, Lilly, Bayer, Pfizer. K.\u00a0Streckfu\u00df-B\u00f6meke gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}